| Trial registration number
|
NCT04406909 |
Full text link
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04406909
|
First author
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Magnus Løberg, MD PhD
|
Contact
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
2020-05-29
|
Recruitment status
Last imported at : June 3, 2022, 2 p.m.
Source : ClinicalTrials.gov
|
Not recruiting
|
Study design
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
all members of participating training facilities age 18 years or older who are not at increased risk for severe covid-19 disease (see www.fhi.no for criteria) are eligible for participation if they
plan to use the training facility regularly during the project period
are willing to adhere to training policies during the project
accept assessment of project endpoints
approve handling of data for the project
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
covid-19 related comorbidity
age below 18 years or above 64 years
|
Number of arms
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Norwegian Department of Health and Social Affairs
|
Inclusion age min
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
64
|
Countries
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Norway
|
Type of patients
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
4000
|
primary outcome
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
COVID-19 RNA test positivity;Hospital admission for COVID-19
|
Notes
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 13, "treatment_name": "Access to training facilities", "treatment_type": "Social distancing", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 898, "treatment_name": "No access to training facilities", "treatment_type": "Social distancing", "pharmacological_treatment": "Non pharmacological treatment"}]
|